- $30.67m
- -$1.61m
- $36.08m
- 30
- 45
- 41
- 32
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 15.8 | 36.1 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 26.7 | 29.5 | 37.8 | 77.8 | 50.6 |
Operating Profit | -26.7 | -29.5 | -37.8 | -62.1 | -14.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -25.6 | -29.8 | -39.1 | -62.4 | -12.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -25.6 | -29.8 | -39.1 | -62.4 | -13.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -25.6 | -29.8 | -39.1 | -62.4 | -13.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -25.6 | -29.8 | -39.1 | -62.4 | -13.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.47 | -1.52 | -1.36 | -1.84 | -0.384 |